Eli Lilly and Company (LLY) Pays Acrux Limited $87M on FDA Approval of Testosterone Replacement Therapy
11/24/2010 6:33:21 AM
More...
|
Eli Lilly and Company (LLY) (JOBS) Gets Rights to Sell Testosterone Drug from Acrux Limited in Deal Worth up to $335 Million
3/16/2010 6:58:43 AM
More...
|
Acrux Limited Announces Successful AXIRON Phase III Trial Results; Trial Met Primary Endpoint
9/29/2009 7:03:14 AM
More...
|
KV Pharmaceutical Company (KV-A) Signs Expanded Worldwide Partnership With Acrux Limited, Including the Development of Six New Branded Products
8/12/2008 6:35:47 AM
More...
|
Acrux Limited Completes $22.5 Million Capital Raising
7/18/2007 12:29:08 PM
More...
|
Acrux Limited to Push on with Phase 3 Testosterone Trial
7/18/2007 12:24:05 PM
More...
|
Acrux Limited Announces Positive Clinical Trial Results with Combination Contraceptive Sprays
7/3/2007 1:00:19 PM
More...
|
Acrux Limited and Organon (AKZOY) to Develop Contraceptive Sprays
3/1/2007 12:14:53 PM
More...
|
Acrux Limited To Start USA Trial Of Its Unique Testosterone Lotion For Men
9/18/2006 12:50:56 PM
More...
|
Acrux Limited Awarded 1st European Patent
4/19/2006 3:44:35 PM
More...
|
|